Venus Remedies gains after receiving good manufacturing certification from Moldova health ministry

Venus Remedies on Tuesday, December 31, said it has received a good manufacturing practice certification from the Ministry of Health of Moldova for its antibiotic-carbapenem facility.

“With this certification, we are now well-positioned to further extend our presence in the eastern European market, ensuring access to high-quality, effective, and reliable antibiotics for healthcare providers and patients across the region,” the company said in an exchange filing.

Earlier this month, the company said it secured marketing authorisation for a cancer treatment drug, Pemetrexed 500mg, in the Philippines. The drug is a chemotherapeutic agent widely used in the treatment of lung cancer and mesothelioma.

Earlier on November 29, Venus Remedies informed the exchanges that its Board of Directors approved the establishment of a wholly-owned subsidiary in Hungary by its wholly-owned subsidiary Venus Pharma GmbH, Germany. The company plans to establish the subsidiary to enhance its market presence in Eastern Europe.

Last month, the company also received Good Manufacturing Practices (GMP) approval from the National Pharmaceutical Regulatory Agency (NPRA) of Malaysia for its pre-filed syringe (PFS) facility in Baddi, Himachal Pradesh.

Venus Remedies shares were trading 3.4% higher at ₹320.6 apiece at 1.30 pm on December 31. It has fallen 20.86% this year, so far.

Also Read: Easy Trip Planners — How retail shareholding went up to 10 lakh from 50,000 in just three years